P e r s i s t e n c e M a r k e t R e s e a r c h
Throughout the forecast period , hospitals will retain as the dominant end-users of wound debridement products in North America . By the end of 2024 , revenues procured from wound debridement products sales to hospitals will be nearly 50 % of the gross estimated revenues . ASCs and specialized clinics are expected to collectively garner over US $ 100 million in revenues by 2024-end , while wound debridement products sales accounted by North American nursing facilities will expand at a moderate CAGR of 4.6 %. Increasing incidences of chronic ulcers in North America is projected to instrument the growth in demand for wound debridement products in hospitals . Revenues generated from the wound debridement products sales in chronic ulcers treatment across North American hospitals are expected to expand at an impressive 8.2 % CAGR over the forecast period .
Download Report Table of Content , Figures , and Tables @ http :// www . persistencemarketresearch . com / market-research / north-america-wounddebridement-products-market / toc
Leading medical devices manufacturers in the US are recognized as some of the key players participating in the growth of wound debridement products market in North America . Companies such as Smith & Nephew PLC , Zimmer Biomet Holdings , Inc ., Misonix , and Lohmann & Rauscher International are known for leading the market in terms of production of effective lowfrequency ultrasound wound debridement products . Derma Sciences Inc . holds an extended product portfolio for surgical wound debridement products and mechanical debridement pads , while BSN Medical specialized in traditional wound debridement and larval therapy products . Arobella Medical LLC , DeRoyal Industries Inc ., and Söring GmbH are some other key manufacturers & suppliers of wound debridement products in North America .
Browse Complete Report @ http :// www . persistencemarketresearch . com / checkout / 12967
North America Wound Debridement Products Market by 2024